Literature DB >> 24330692

Value of impedance cardiography during 6-minute walk test in pulmonary hypertension.

Adriano R Tonelli1, Laith Alkukhun, Vineesha Arelli, José Ramos, Jennie Newman, Kevin McCarthy, Bohdan Pichurko, Omar A Minai, Raed A Dweik.   

Abstract

BACKGROUND: Methods that predict prognosis and response to therapy in pulmonary hypertension (PH) are lacking. We tested whether the noninvasive estimation of hemodynamic parameters during 6-minute walk test (6MWT) in PH patients provides information that can improve the value of the test.
METHODS: We estimated hemodynamic parameters during the 6MWT using a portable, signal-morphology-based, impedance cardiograph (PhysioFlow Enduro) with real-time wireless monitoring via a bluetooth USB adapter.
RESULTS: We recruited 48 subjects in the study (30 with PH and 18 healthy controls). PH patients had significantly lower maximum stroke volume (SV) and CI and slower cardiac output (CO) acceleration and decelerations slopes during the test when compared with healthy controls. In PH patients, CI change was associated with total distance walked (R = 0.62; P < 0.001) and percentage of predicted (R = 0.4, P = 0.03), HR recovery at 1 minute (0.57, P < 0.001), 2 minutes (0.65, P < 0.001), and 3 minutes (0.66, P < 0.001). Interestingly, in PH patients CO change during the test was predominantly related to an increase in SV instead of HR.
CONCLUSIONS: Estimation of hemodynamic parameters such as cardiac index during 6-minute walk test is feasible and may provide useful information in patients with PH. Clin Trans Sci 2013; Volume #: 1-7.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  6-minute walk test; cardiac output; pulmonary hypertension

Mesh:

Year:  2013        PMID: 24330692      PMCID: PMC4286797          DOI: 10.1111/cts.12090

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  43 in total

Review 1.  Updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; Ivan M Robbins; Maurice Beghetti; Richard N Channick; Marion Delcroix; Christopher P Denton; C Gregory Elliott; Sean P Gaine; Mark T Gladwin; Zhi-Cheng Jing; Michael J Krowka; David Langleben; Norifumi Nakanishi; Rogério Souza
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

2.  Cardiopulmonary exercise testing in patients with pulmonary arterial hypertension: an evidence-based review.

Authors:  Ross Arena; Carl J Lavie; Richard V Milani; Jonathan Myers; Marco Guazzi
Journal:  J Heart Lung Transplant       Date:  2009-12-06       Impact factor: 10.247

3.  Sildenafil citrate therapy for pulmonary arterial hypertension.

Authors:  Nazzareno Galiè; Hossein A Ghofrani; Adam Torbicki; Robyn J Barst; Lewis J Rubin; David Badesch; Thomas Fleming; Tamiza Parpia; Gary Burgess; Angelo Branzi; Friedrich Grimminger; Marcin Kurzyna; Gérald Simonneau
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

4.  Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.

Authors:  Vallerie V McLaughlin; Raymond L Benza; Lewis J Rubin; Richard N Channick; Robert Voswinckel; Victor F Tapson; Ivan M Robbins; Horst Olschewski; Melvyn Rubenfire; Werner Seeger
Journal:  J Am Coll Cardiol       Date:  2010-05-04       Impact factor: 24.094

5.  Sildenafil improves cardiac output and exercise performance during acute hypoxia, but not normoxia.

Authors:  Andrew R Hsu; Kimberly E Barnholt; Nicolas K Grundmann; Joseph H Lin; Stewart W McCallum; Anne L Friedlander
Journal:  J Appl Physiol (1985)       Date:  2006-02-02

6.  Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension.

Authors:  S Provencher; D Chemla; P Hervé; O Sitbon; M Humbert; G Simonneau
Journal:  Eur Respir J       Date:  2006-01       Impact factor: 16.671

7.  Exercise stress echocardiography for the study of the pulmonary circulation.

Authors:  P Argiento; N Chesler; M Mulè; M D'Alto; E Bossone; P Unger; R Naeije
Journal:  Eur Respir J       Date:  2009-11-19       Impact factor: 16.671

8.  Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension.

Authors:  S Provencher; P Hervé; O Sitbon; M Humbert; G Simonneau; D Chemla
Journal:  Eur Respir J       Date:  2008-04-16       Impact factor: 16.671

9.  Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.

Authors:  Gérald Simonneau; Lewis J Rubin; Nazzareno Galiè; Robyn J Barst; Thomas R Fleming; Adaani E Frost; Peter J Engel; Mordechai R Kramer; Gary Burgess; Lorraine Collings; Nandini Cossons; Olivier Sitbon; David B Badesch
Journal:  Ann Intern Med       Date:  2008-10-21       Impact factor: 25.391

10.  Impedance cardiography: A valuable method of evaluating haemodynamic parameters.

Authors:  Tomasz Sodolski; Andrzej Kutarski
Journal:  Cardiol J       Date:  2007       Impact factor: 2.737

View more
  9 in total

1.  Comparison of electrical velocimetry and cardiac magnetic resonance imaging for the non-invasive determination of cardiac output.

Authors:  Frederik Trinkmann; Manuel Berger; Christina Doesch; Theano Papavassiliu; Stefan O Schoenberg; Martin Borggrefe; Jens J Kaden; Joachim Saur
Journal:  J Clin Monit Comput       Date:  2015-06-27       Impact factor: 2.502

Review 2.  The Utility of Exercise Testing in Patients with Lung Cancer.

Authors:  Duc Ha; Peter J Mazzone; Andrew L Ries; Atul Malhotra; Mark Fuster
Journal:  J Thorac Oncol       Date:  2016-05-05       Impact factor: 15.609

3.  Heart rate slopes during 6-min walk test in pulmonary arterial hypertension, other lung diseases, and healthy controls.

Authors:  Adriano R Tonelli; Xiao-Feng Wang; Laith Alkukhun; Qi Zhang; Raed A Dweik; Omar A Minai
Journal:  Physiol Rep       Date:  2014-06-11

4.  Inorganic nitrate as a treatment for acute heart failure: a protocol for a single center, randomized, double-blind, placebo-controlled pilot and feasibility study.

Authors:  Roman Falls; Michael Seman; Sabine Braat; Joshua Sortino; Jason D Allen; Christopher J Neil
Journal:  J Transl Med       Date:  2017-08-08       Impact factor: 5.531

5.  Noninvasive investigation of the cardiodynamic response to 6MWT in people after stroke using impedance cardiography.

Authors:  Fang Liu; Alice Y M Jones; Raymond C C Tsang; Yao Wang; Jing Zhou; Mingchao Zhou; Yulong Wang
Journal:  PLoS One       Date:  2020-06-17       Impact factor: 3.240

6.  Stroke volume and cardiac output during 6 minute-walk tests are strong predictors of maximal oxygen uptake in people after stroke.

Authors:  Fang Liu; Alice Y M Jones; Raymond C C Tsang; Fubing Zha; Mingchao Zhou; Kaiwen Xue; Zeyu Zhang; Yulong Wang
Journal:  PLoS One       Date:  2022-08-30       Impact factor: 3.752

7.  Cardiodynamic variables measured by impedance cardiography during a 6-minute walk test are reliable predictors of peak oxygen consumption in young healthy adults.

Authors:  Fang Liu; Raymond C C Tsang; Alice Y M Jones; Mingchao Zhou; Kaiwen Xue; Miaoling Chen; Yulong Wang
Journal:  PLoS One       Date:  2021-05-25       Impact factor: 3.240

8.  Electrical Bioimpedance Spectroscopy on Acute Unilateral Stroke Patients: Initial Observations regarding Differences between Sides.

Authors:  Fernando Seoane; Seyed Reza Atefi; Jens Tomner; Konstantinos Kostulas; Kaj Lindecrantz
Journal:  Biomed Res Int       Date:  2015-10-18       Impact factor: 3.411

9.  Cardiopulmonary factors affecting 6-min walk distance in patients with idiopathic inflammatory myopathies.

Authors:  Naoki Mugii; Fujiko Someya
Journal:  Rheumatol Int       Date:  2018-05-14       Impact factor: 2.631

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.